Royal Fund Management LLC Sells 5,050 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Royal Fund Management LLC decreased its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 13.5% during the 2nd quarter, Holdings Channel.com reports. The fund owned 32,405 shares of the real estate investment trust’s stock after selling 5,050 shares during the quarter. Royal Fund Management LLC’s holdings in Omega Healthcare Investors were worth $1,111,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in OHI. Versant Capital Management Inc acquired a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at $26,000. MeadowBrook Investment Advisors LLC bought a new position in Omega Healthcare Investors during the fourth quarter worth about $31,000. GAMMA Investing LLC bought a new position in Omega Healthcare Investors during the fourth quarter worth about $35,000. WFA Asset Management Corp acquired a new position in shares of Omega Healthcare Investors during the 1st quarter worth about $39,000. Finally, Covestor Ltd increased its stake in shares of Omega Healthcare Investors by 47.6% in the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after acquiring an additional 431 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Down 0.4 %

Shares of Omega Healthcare Investors stock traded down $0.15 during trading hours on Friday, reaching $37.43. 1,674,858 shares of the company’s stock were exchanged, compared to its average volume of 1,700,975. The company has a current ratio of 6.68, a quick ratio of 6.68 and a debt-to-equity ratio of 1.36. The company has a 50 day moving average of $35.01 and a two-hundred day moving average of $32.33. The stock has a market cap of $9.25 billion, a P/E ratio of 33.72, a P/E/G ratio of 1.43 and a beta of 0.97. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $38.85.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.68%. The company had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. During the same quarter in the prior year, the business earned $0.74 earnings per share. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. On average, sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.64 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Monday, August 5th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 7.16%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio is currently 241.44%.

Analysts Set New Price Targets

Several research firms recently weighed in on OHI. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a research note on Monday, May 6th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Wells Fargo & Company raised Omega Healthcare Investors to a “strong-buy” rating in a research note on Friday, June 14th. Truist Financial boosted their target price on Omega Healthcare Investors from $32.00 to $33.00 and gave the company a “hold” rating in a research note on Wednesday, June 26th. Finally, Scotiabank boosted their price objective on Omega Healthcare Investors from $32.00 to $33.00 and gave the company a “sector perform” rating in a research report on Tuesday, July 9th. Nine investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $33.67.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.